Compliance training
XLS |
Compliance training |
||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
|
20171 |
|
20181 |
|
20192,3 |
|
2020 |
|
2020 |
||||||||||||||
Total number of persons trained on anti-corruption guidelines6 |
|
17,044 |
|
11,404 |
|
36,109 |
|
28,827 |
|
3,880 |
||||||||||||||
Total number of employees trained on anti-corruption guidelines |
|
13,345 |
|
11,155 |
|
35,673 |
|
28,805 |
|
3,877 |
||||||||||||||
% of employees trained on anti-corruption |
|
25 |
|
22 |
|
63 |
|
50 |
|
45 |
||||||||||||||
by employee category |
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Number of Role 2+ employees trained on anti-corruption |
|
7,080 |
|
9,257 |
|
26,890 |
|
27,123 |
|
3,848 |
||||||||||||||
% of Role 2+ employees trained on anti-corruption |
|
27 |
|
36 |
|
96 |
|
90 |
|
93 |
||||||||||||||
% of employees below Role 2 trained on anti-corruption |
|
23 |
|
7 |
|
30 |
|
6 |
|
1 |
||||||||||||||
by region (%) |
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Europe |
|
18 |
|
19 |
|
71 |
|
51 |
|
45 |
||||||||||||||
North America |
|
46 |
|
36 |
|
59 |
|
45 |
|
not applicable |
||||||||||||||
Asia-Pacific (APAC) |
|
25 |
|
16 |
|
47 |
|
44 |
|
not applicable |
||||||||||||||
Latin America |
|
19 |
|
12 |
|
62 |
|
44 |
|
not applicable |
||||||||||||||
Middle East and Africa (MEA) |
|
29 |
|
18 |
|
80 |
|
66 |
|
not applicable |
||||||||||||||
|
The (employee) target audience for a specific training is related to the risk level associated with employee positions and Role levels. Target audiences therefore may not include all Group employees and also may vary from training to training.
In order to address the special responsibility held by management personnel, and staff with HR responsibility, trainings on anti-corruption guidelines for these employees are in focus. This applies to all employees rated Role 2+.
Our compliance and anti-corruption principles are communicated to all our business partners who undergo a Business Partner Risk Management (BPRM) process.
Internal audits on corruption and Human Rights Charter
XLS |
Internal audits on corruption and Human Rights Charter |
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
2017 |
|
2018 |
|
2019 |
|
2020 |
|
2020 |
||||
Number of audits relating to corruption |
|
50 |
|
54 |
|
50 |
|
52 |
|
26 |
||||
% of audits relating to corruption |
|
65 |
|
69 |
|
65 |
|
66 |
|
33 |
||||
Number of audits relating to the workplace requirements of our Human Rights Charter |
|
45 |
|
46 |
|
46 |
|
42 |
|
20 |
||||
|
In 2020, during 42 of our audits conducted in 14 countries, we reviewed workplace parameters as per our Human Rights Charter. No violations were identified.
Human rights violations
XLS |
Human rights violations1 |
||||||||||||||
|
|
|
|
|
|
|
|
|
||||||
|
|
20172 |
|
20182 |
|
20192 |
|
2020 |
||||||
Number of reported violations of Social and Labor Standards Policy |
|
- |
|
- |
|
- |
|
108 |
||||||
Number of confirmed Violations of Social and Labor Standards Policy |
|
- |
|
- |
|
- |
|
29 |
||||||
thereof number of incidents of discrimination |
|
- |
|
- |
|
- |
|
2 |
||||||
|
Reported compliance violations
XLS |
Reported compliance violations |
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
2017 |
|
2018 |
|
2019 |
|
2020 |
|
2020 |
||||
Total number of reported compliance violations |
|
|
|
|
|
|
|
|
|
|
||||
Number of reported compliance incidents |
|
39 |
|
72 |
|
75 |
|
81 |
|
8 |
||||
Number of confirmed cases |
|
14 |
|
19 |
|
30 |
|
41 |
|
3 |
||||
Confirmed cases by category1 |
|
|
|
|
|
|
|
|
|
|
||||
Bribery and corruption |
|
3 |
|
3 |
|
9 |
|
6 |
|
0 |
||||
Violation of cartel laws and fair competition rules |
|
0 |
|
1 |
|
0 |
|
0 |
|
0 |
||||
Fraudulent actions against Merck |
|
1 |
|
5 |
|
8 |
|
11 |
|
0 |
||||
Other violations of the Merck Compliance Principles for the relations with business partners |
|
2 |
|
1 |
|
4 |
|
0 |
|
0 |
||||
Other violations of Merck values, internal guidelines or legal requirements |
|
8 |
|
9 |
|
9 |
|
24 |
|
3 |
||||
|
Revisions to the table have resulted in the following changes: The category “Violation of the Human Rights Charter” is now being disclosed in the new “Human rights violations” table. As of 2020, the category “Violation of Data Privacy” will be reported separately in the “Data privacy” table.
The category “Violation of the Merck Pharmaceutical Guidelines” was partially merged with “Bribery and corruption”. Going forward, the category “Other violations of values, internal guidelines or legal requirements” will include violations from “Manipulation of business documents” and “Infringements in the areas of finance, accounting and banking”, along with violations that used to be reported in part under “Violation of the Merck Pharmaceutical Guidelines” or “Violation of Confidentiality Guidelines”.
Data Privacy
XLS |
Data Privacy |
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
2017 |
|
2018 |
|
20191 |
|
2020 |
|
2020 |
||||||||
Reported violations of Data Privacy Guidelines |
|
-2 |
|
1 |
|
1 |
|
3 |
|
3 |
||||||||
Customer Privacy3 |
|
|
|
|
|
|
|
|
|
|
||||||||
Total number of substantiated complaints received from outside parties |
|
0 |
|
0 |
|
0 |
|
0 |
|
0 |
||||||||
Total number of complaints from regulatory bodies |
|
0 |
|
0 |
|
1 |
|
0 |
|
0 |
||||||||
Total number of identified leaks, thefts, or losses of customer data |
|
0 |
|
1 |
|
1 |
|
0 |
|
0 |
||||||||
|
As of 2020, this table presents the number of reported cases of data privacy violations. In the previous years, we reported data privacy violations in one line combined with violations of confidentiality guidelines in the table entitled “Reported Compliance Violations”. For more information, please see the table entitled Reported Compliance Violations.
Legal actions
XLS |
Legal actions |
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
2017 |
|
20181 |
|
2019 |
|
2020 |
|
2020 |
||||||
Total number2 of legal actions pending or completed (for anti-competitive behavior, violations of anti-trust or violations of monopoly legislation) |
|
3 |
|
3 |
|
3 |
|
4 |
|
2 |
||||||
pending |
|
3 |
|
3 |
|
3 |
|
4 |
|
2 |
||||||
completed |
|
0 |
|
0 |
|
0 |
|
0 |
|
0 |
||||||
|
For further information please see our annual reports:
- Annual Report 2017, pages 148-150 and pages 252-253, No. 27
- Annual Report 2018, pages 146-148 and pages 247-251, No. 26
- Annual Report 2019, pages 115-117 and pages 231-233, No. 26
- Annual Report 2020, pages 125-127 and pages 252-256, No. 27